News
Stay Ahead with the Latest Industry Trends & Market Insights with Industry News 📰

Foot Drop Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: February 2024 || SKU: MD4449
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Get Free Sample

See how US Tariffs impact Foot Drop Treatment Market

Don’t get caught off guard!

Global Foot Drop Treatment Market is segmented By Product Type (Electrical Stimulator, Braces/Splints, Other), By Application (Neuropathy, Muscle Disorders, Brain & Spinal Disorders, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023- 2030

 

Foot Drop Treatment Market Overview

180 pages report analyses the Foot Drop Treatment Market Share, Trends and Growth. Foot Drop Treatment Market is estimated to reach  at a high CAGR 8.7% during the forecast period (2023- 2030). Foot drop is a weakness experienced when lifting the foot and toes upward. It is characterized by the individual dragging the toes of the affected foot involuntarily while attempting to walk. To compensate for the dragging, a high steppage or slapping gait is attempted, in which the leg on the dramatic side is lifted more elevated than usual for the toes to clear the surface. North America region accounted for the largest market share. Competitive rivalry intensifies with NextStep Robotics, Ottobock, Bioness Inc. and others operating in the market.

 

Foot Drop Treatment Market Scope

Metrics

Details

Market CAGR

8.7%

Segments Covered

By Product Type, By Application, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Largest Market Share 

North America

 

For More Insights Download Sample

 

Foot Drop Treatment Market Dynamics

The recent emerging treatments for foot drop are expected to drive the market growth in the forecast period.

The majority of neurological impairments affecting gaits, such as a cerebrovascular accident (CVA) or stroke, spinal cord injuries (SCIs), multiple sclerosis (MS), cerebral palsy (CP), and brain injuries (BIs), occur at high rates worldwide. Foot drop (FD) is a common gait impairment caused by these pathologies, and it is characterized by paralysis or significant weakness of the ankle dorsiflexor muscles.

It is distinguished by the inability to achieve adequate dorsiflexion to achieve a sufficient distance with the ground during the swing phase of gait. It is also determined by uncontrolled plantarflexion, which results in foot slap. Individuals with FD may become unable to support their weight due to muscle weakness and spasticit. Therefore, it is vital to identify appropriate strategies of intervention to overcome foot drop symptoms and improve gait.

For instance, conventional treatment involves using an ankle-foot orthosis (AFO), which keeps the ankle joint neutral. However, robotic and electrical stimulation assistance techniques are being developed and represent promising alternatives. The most commonly used methods to compensate for FD are functional electrical stimulation (FES), which sequentially activates paralyzed muscles through electrical stimulation to restore functional movement and is clinically beneficial in gait restoration, and transcutaneous electrical nerve stimulation (TENS), which is a non-invasive technique that is typically used as analgesic treatment. These two techniques have different effects on Foot drop. Still, in both of them, the second motor neuron must be intact, as well as the electrical excitability in the peripheral nerves and muscle tissues.

Moreover, Heliyon published a study in 2020 in which a Pedi-anklebot robot was evaluated for foot drop treatment. Ankle motor performance was measured, and excellent accuracy in ankle trajectories was observed. Hence, the new emerging treatment options are expected to drive the global foot drop treatment market in the forecast period.

The availability of alternative treatment is expected to hamper the market growth.

In recent times people are opting for natural ways of treatment. For instance, the most effective natural remedy for foot drop is to retrain the brain to activate the muscles that control dorsiflexion. The brain already knows how to do this due to neuroplasticity, which forms new neural pathways based on what one repeatedly practices. Even if one can't dorsiflex right now, the brain can do so with foot drop exercises.

Foot drop exercises use movements such as dorsiflexion to retrain the brain on how to lift the front of the foot. The more one does foot drop exercises, the better dorsiflexion will become. Each repetition of the foot drop exercises strengthens the new neural pathways in the brain that can control dorsiflexion. Natural foot drop remedies are particularly effective because they address the underlying problem: the brain-muscle connection.

On the other hand, drugs and surgery avoid this issue and, as a result, do not produce the best results. In this case, homeopathic remedies are the most effective method of recovering from foot drops. According to the World Health Organization, herbal medicine is used by an estimated 80% of the world's population. Certain herbs have been shown in studies to effectively treat a variety of health issues, including allergies, fatigue, and others.

COVID-19 Impact On Foot Drop Treatment Market

The COVID-19 pandemic has affected approximately 65 million people worldwide. Isolated peroneal nerve palsy was developed in many people after recovery. For instance, infection with SARS-CoV-2 in addition, the patients had foot problems, weakness 7-10 days after recovering from acute primary SARSCoV-2 infection, implying the possibility of immune-mediated infection. Acute Respiratory Syndrome with Severe Exacerbation Coronavirus 2 (SARS-CoV-2) virus, which caused the Coronavirus Disease 2019 (COVID-19) pandemic, may also affect the neural axis at various levels, including the CNS and the Peripheral Nervous System (PNS).

There is mounting evidence that SARS-CoV-2 is causing neurological complications. Although isolated facial nerve involvement has been reported, isolated peroneal nerve palsy due to SARS-CoV-2 infection is uncommon. A study said two such rare cases of foot drop (53-year-old male/45-year-old male) where separated peroneal nerve involvement was found on a nerve conduction study. Hence, with the increasing effect of COVID-19, the global foot drop treatment market is expected to grow.

Foot Drop Treatment Market Segmentation Analysis

The electric stimulation segment is expected to dominate the market growth.

Foot drop is typically treated with orthotics such as an ankle-foot orthosis (AFO), physical therapy, or surgery. Nerve stimulation, using myoelectric orthotics such as functional electrical stimulators (FES), is a rehabilitation technique that uses electrical currents to peripheral nerves to improve the movement or function of organs, muscles, and extremities. It is used during rehabilitation for adults and children with neurologic dysfunction such as foot drop. FES has been shown to help patients with foot drops caused by various neurological conditions improve many aspects of their walking.

For instance, The Functional Electrical Stimulator (FES) stimulates tissues with electrical pulses, improving motion, increasing blood circulation, and preventing muscular atrophy. According to a 2019 study published in World Neurology, an FES was evaluated for its effectiveness in regaining foot functionality. FES was influential in the case of regular walk-in neurogenic drop foot patients. Furthermore, the rising prevalence of brain and spinal disorders is expected to impact the FES segment market positively. According to the Neurological Alliance, most cerebral palsy in England in 2018 was approximately 25,273.

Foot Drop Treatment Market Geographical Share

North America region is expected to hold the largest market share in the global foot drop treatment market.

The high prevalence of stroke and the growing number of product approvals. Stroke is a common cause of foot drop, which makes walking difficult. Foot drop patients cannot raise the front part of their foot due to muscle weakness that generally lifts it. According to the Centers for Disease Control and Prevention, approximately 795,000 people in the United States suffer from a stroke each year.

The increasing FDA approvals are also expected to fuel the market growth. For instance, Bioness Inc. received US FDA (Food Drug & Administration) support for its L300 Go system in 2017. It includes user activity tracking, 3D motion detection of gait movements, and multi-channel stimulation. As a result of these factors, the demand for foot drop treatment in this region is expected to increase.

Foot Drop Treatment Companies and Competitive Landscape

The global foot drop treatment market is highly competitive with increasing product launches, company mergers and acquisitions. Some of the key players in the market are NextStep Robotics, Ottobock, Bioness Inc., Axio Bionics, Accelerated Care Plus Corporation, Saebo, Inc., Boston Orthotics & Prosthetics, Turbomed Orthotics, Ossur, Thrive Orthopedics.

Saebo Inc.

Overview: Saebo, Inc. is a medical device company focused on discovering, developing, and commercializing low-cost, novel clinical solutions to improve mobility and function in people with neurological and orthopedic conditions.

Product Portfolio: The company's device called "SaeboStep" has is used to treat foot drop. Its distinct design and lightweight complement a wide range of footwear.

Key Development: On May 25, 2017, the company launched a new device called "SaeboStep" to treat foot drops. Its distinct design and lightweight complement a wide range of footwear.

On May 14, 2019, NextStep Robotics, a Baltimore-based startup, closed a $600,000 funding round to advance the development of its stroke rehabilitation device. The company's robotic device is intended to treat foot drop, a common problem for stroke survivors that prevents them from lifting a toe while walking. This restricts mobility and increases the risk of falling.

Buy this report
Single User
$4350$3480
Multiple User
$4850$3880
Enterprise User
$7850$6280
Proceed to Buy
  Get Free Sample
  Request new version
  Customize Sample
  Demo Full Report
Chat on WhatsApp
FAQ’s

  • The foot drop treatment market is anticipated to experience a significant growth rate of 8.7% during the forecast period between 2023 and 2030, driven by rising neurological disorders and emerging treatment options.

  • Conventional treatments involve ankle-foot orthosis (AFO) and physical therapy. However, advancements in technology have led to the development of promising alternatives like functional electrical stimulation (FES) and robotic-assisted therapies.

  • The increasing prevalence of neurological conditions like stroke, spinal cord injuries, and multiple sclerosis is a major driver. Additionally, growing awareness of treatment options, product advancements, and rising disposable incomes contribute to market expansion.

  • Major players are NextStep Robotics, Ottobock, Bioness Inc., Axio Bionics, Accelerated Care Plus Corporation, Saebo, Inc., Boston Orthotics & Prosthetics, Turbomed Orthotics, Ossur, Thrive Orthopedics.
Related Reports
pharmaceuticals iconpharmaceuticals

Pneumothorax Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2023 June 28

Starting from

$4350

pharmaceuticals iconpharmaceuticals

Porphyria Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 November 18

Starting from

$4350

pharmaceuticals iconpharmaceuticals

Vertigo Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 November 18

Starting from

$4350

pharmaceuticals iconpharmaceuticals

Hematuria Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 November 18

Starting from

$4350

medical-devices iconmedical-devices

Aerosol Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 01

Starting from

$4350

pharmaceuticals iconpharmaceuticals

Keloid Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 September 11

Starting from

$4350

WhatsApp